Invivyd, Inc.
IVVD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001832038
In the last 90 days, Invivyd, Inc. insiders filed 0 open-market purchases and 5 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $203.1M in total; Maverick Capital is the only superinvestor holding it.
Superinvestors holding IVVD, Q2 2026
1 superinvestor reports holding Invivyd, Inc. on Form 13F, worth $16.6M in total. Weight is Invivyd, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Maverick CapitalLee Ainslie | 0.1% | 18,970,913 | $16.6M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of IVVD each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2025
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+85.5%)
Q2 2025
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−6.7%)
- Sold out
- Duquesne Family Office
Q1 2025
2 superinvestors holding at quarter end
- Reduced
- Maverick Capital (−6.9%)
Q2 2024
2 superinvestors holding at quarter end
Q1 2024
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+25.9%)
Q4 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+77.3%)
Q3 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+125.4%)
Q2 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+23.9%)
Q1 2023
1 superinvestor holding at quarter end
Q2 2022
0 superinvestors holding at quarter end
- Sold out
- Third Point
Q1 2022
1 superinvestor holding at quarter end
- New
- Third Point